Treatment of acute myelogenous leukemia in children and adults.

We designed a protocol to address the problem of relapse from complete remission in acute myelogenous leukemia. Patients in remission were treated for 14 months; early and later intensification of chemotherapy, sequential drug combinations, and high-dose continuous infusions of cytarabine were included. Eighty-three consecutive patients under 50 years of age were entered into this study from February 1976 to October 1979. The rate of complete remission is 70 per cent. A Kaplan-Meier analysis predicts that 49 +/- 17 per cent of patients (mean +/- 2 S.D.) who entered complete remission will remain free of disease at two years. Durations of complete remission for patients in the 0 to 17-year and 18 to 50-year age groups are comparable.

[1]  D. Hedley,et al.  THE PLACE OF BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKÆMIA , 1980, The Lancet.

[2]  E. Scott,et al.  Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia. , 1980, The New England journal of medicine.

[3]  J. Karp,et al.  Long chemotherapy‐free remissions after single‐cycle timed‐sequential chemotherapy for acute myelocytic leukemia , 1980, Cancer.

[4]  P. Neiman,et al.  Marrow transplantation for acute nonlymphoblastic leukemia in first remission. , 1979, The New England journal of medicine.

[5]  J. Adamson,et al.  Acute nonlymphocytic leukemia: expression in cells restricted to granulocytic and monocytic differentiation. , 1979, The New England journal of medicine.

[6]  R. Gale.  Advances in the treatment of acute myelogenous leukemia. , 1979, The New England journal of medicine.

[7]  D. Pinkel.  The ninth annual david karnofsky lecture. Treatment of acute lymphocytic leukemia , 1979, Cancer.

[8]  G. Harding,et al.  A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients. , 1979, The American journal of medicine.

[9]  G. Dahl,et al.  Preventive central nervous system irradiation in children with acute nonlymphocytic leukemia , 1978, Cancer.

[10]  J. Rowley,et al.  Correlation of clinical findings with quinacrine-banded chromosomes in 90 adults with acute nonlymphocytic leukemia: an eight-year study (1970-1977). , 1978, The New England journal of medicine.

[11]  E. Gehan,et al.  Therapy of acute myelogenous leukemia , 1978 .

[12]  H. Sather,et al.  Increased survival in childhood acute nonlymphocytic leukemia after treatment with prednisone, cytosine arabinoside, 6-thioguanine, cyclophosphamide, and oncovin (PATCO) combination chemotherapy. , 1978, Medical and pediatric oncology.

[13]  M. Murphy,et al.  Treatment of acute nonlymphoblastic leukemia in children with a multiple‐drug protocol , 1977, Cancer.

[14]  C. Bloomfield,et al.  PROLONGED MAINTAINED REMISSIONS OF ADULT ACUTE NON-LYMPHOCYTIC LEUKAEMIA , 1977, The Lancet.

[15]  R. Gale,et al.  HIGH REMISSION-INDUCTION RATE IN ACUTE MYELOID LEUKÆMIA , 1977, The Lancet.

[16]  T. Lister,et al.  Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient. , 1977, British Journal of Cancer.

[17]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[18]  J. Rowley,et al.  Chromosomal banding patterns in acute nonlymphocytic leukemia. , 1976, Blood.

[19]  E. Gehan,et al.  Late intensification therapy for acute leukemia in remission. Chemotherapy and immunotherapy. , 1976, JAMA.

[20]  A. Sandberg,et al.  Chromosomes and causation of human cancer and leukemia. XI. Correlation of karyotypes with clinical features of acute myeloblastic leukemia , 1976, Cancer.

[21]  Young Rc,et al.  Hematologic malignancies and other marrow failure states: progress in the management of complicating infections. , 1974 .

[22]  C. Bloomfield,et al.  Acute granulocytic leukemia in elderly patients. , 1973, JAMA.

[23]  R. Aur,et al.  Comparison of two methods of preventing central nervous system leukemia. , 1973, Blood.

[24]  R. Graw,et al.  Principles of hematologic supportive care. , 1973, The Medical clinics of North America.

[25]  D. Ho,et al.  Clinical pharmacology of l‐β‐D‐arabinofuranosyl cytosine , 1971 .

[26]  S. George,et al.  Cytogenetic studies and their clinical correlates in adults with acute leukemia. , 1971, Annals of internal medicine.

[27]  P. Wiernik,et al.  FACTORS EFFECTING REMISSION AND SURVIVAL IN ADULT ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL) , 1970, Medicine.

[28]  J. Harris,et al.  Therapy for acute granulocytic leukemia. , 1967, Cancer research.